See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2016_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 201,394,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 10,960,000 |
| 2 | PropertyPlantAndEquipmentNet | 21,915,000 |
| 3 | remainder_Assets | 611,000 |
| 4 | LiabilitiesCurrent | 103,746,000 |
| 5 | LiabilitiesNoncurrent | 257,655,000 |
| 6 | remainder_Liabilities | 57,168,000 |
| 7 | CostOfGoodsAndServicesSold | 46,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 194,020,682 |
| 9 | ResearchAndDevelopmentExpense | 164,665,411 |
| 10 | remainder_Expenses | 20,396,251 |
| 11 | remainder_Revenues | 91,107,513 |
| 12 | remainder_NetIncome | 989,312 |
| 13 | remainder_ComprehensiveNetIncome | 124,720 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 234,880,000 |
| 1 | Liabilities | 418,569,000 |
| 2 | Expenses | 379,128,344 |
| 3 | Revenues | 91,107,513 |
| 4 | StockholdersEquity | -183,689,000 |
| 5 | NetIncome | -287,031,519 |
| 6 | ComprehensiveNetIncome | -286,969,159 |
| 7 | BaseVar | 562,399,444 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.10 |
| 9 | EconomicCapitalRatio | 0.990 |
Edgar->Model Mapping
Feature Distribution
Change over Time
